Bain Capital Specialty Finance, Inc. (BCSF) Key Metrics
BCSF valuation today
Trailing 12 months · as of October 17, 2026- Market cap
- $665.6M
- Enterprise value
- $2.05B
- P/E (TTM)
- 10.4 10-yr median 9.3
- Forward P/E
- 10.1
- PEG ratio
- 1.05
- Price / sales
- 2.5 10-yr median 7.3
- Price / book
- 0.7 10-yr median 0.8
- EV / EBITDA
- 21.9 10-yr median 22.3
- Dividend yield
- 16.37% $1.68 a year
- Beta
- 0.65
BCSF key metrics, 2016–2025
Fiscal year ended December 31, 2025 · U.S. dollarsBCSF valuation Price multiples at each fiscal year-end price.
BCSF returns How much profit the business earns on the capital it uses.
BCSF per-share figures Results divided by the shares outstanding at year-end.
BCSF financial health Debt, liquidity and how easily interest is covered.
BCSF efficiency & capital use Working capital cycle and where the cash goes.
BCSF valuation history
BCSF returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
BCSF debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
BCSF cash returned to shareholders
BCSF price vs earnings per share
BCSF key metrics
2016–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $901.7M | $1.13B | $973.0M | $768.3M | $982.0M | $711.7M | $1.01B | $643.7M | — | — |
| Enterprise value | $2.24B | $2.47B | $2.18B | $2.09B | $2.28B | $2.12B | $2.55B | $1.26B | — | — |
| P/E ratio | 9.1 | 9.5 | 7.9 | 7.3 | 8.2 | 86.0 | 10.3 | 24.2 | — | — |
| Price / sales | 3.8 | 5.3 | 4.5 | 6.6 | 7.9 | 51.2 | 10.7 | 8.7 | — | — |
| Price / book | 0.8 | 1.0 | 0.9 | 0.7 | 0.9 | 0.7 | 1.0 | 0.6 | — | — |
| Price / free cash flow | 30.5 | 10.0 | 7.7 | — | 3.7 | 8.0 | — | — | — | — |
| Price / operating cash flow | 30.5 | 10.0 | 7.7 | — | 3.7 | 8.0 | — | — | — | — |
| EV / sales | 9.4 | 11.6 | 10.0 | 18.0 | 18.4 | 152.1 | 26.9 | 17.2 | — | — |
| EV / EBITDA | 11.9 | 19.9 | 17.2 | 13.2 | 24.8 | 247.9 | 26.0 | 24.9 | — | — |
| EV / free cash flow | 75.8 | 21.9 | 17.3 | — | 8.6 | 23.7 | — | — | — | — |
| Earnings yield | 11.0% | 10.6% | 12.7% | 13.7% | 12.2% | 1.2% | 9.7% | 4.1% | — | — |
| Free cash flow yield | 3.3% | 10.0% | 12.9% | −41.2% | 27.0% | 12.6% | −23.9% | −120.3% | — | — |
| Dividend yield | 16.2% | 10.1% | 10.2% | 11.4% | 8.9% | 12.1% | 8.0% | 6.4% | — | — |
| Shareholder yield (dividends + buybacks) | 16.2% | 10.1% | 10.2% | 11.4% | 8.9% | 12.1% | 8.0% | 6.4% | — | — |
| Share price at fiscal year-end | $13.91 | $17.52 | $15.07 | $11.90 | $15.21 | $12.13 | $19.39 | $16.46 | — | — |
| Per share | ||||||||||
| Revenue per share | $3.69 | $3.30 | $3.38 | $1.80 | $1.92 | $0.24 | $1.81 | $1.88 | $1.24 | $0.11 |
| Earnings per share | $1.52 | $1.85 | $1.91 | $1.63 | $1.86 | $0.14 | $1.87 | $0.68 | $0.97 | $0.03 |
| Operating cash flow per share | $0.46 | $1.74 | $1.95 | −$4.91 | $4.11 | $1.52 | −$4.64 | −$19.80 | −$35.18 | −$5.08 |
| Free cash flow per share | $0.46 | $1.74 | $1.95 | −$4.91 | $4.11 | $1.52 | −$4.64 | −$19.80 | −$35.18 | −$5.08 |
| Cash per share | $2.09 | $0.83 | $0.77 | $0.93 | $1.82 | $0.93 | $0.71 | $0.39 | $7.11 | $3.37 |
| Book value per share | $17.24 | $17.65 | $17.60 | $17.29 | $17.04 | $18.20 | $19.46 | $25.61 | $25.57 | $5.57 |
| Tangible book value per share | $17.24 | $17.65 | $17.60 | $17.29 | $17.04 | $18.20 | $19.46 | $25.61 | $25.57 | $5.57 |
| Dividends per share | $2.25 | $1.77 | $1.54 | $1.36 | $1.36 | $1.47 | $1.55 | $1.05 | $0.39 | $0.39 |
| Capex per share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Debt per share | $22.69 | $21.53 | $19.45 | $21.46 | $21.92 | $24.86 | $30.09 | $16.23 | $22.75 | $2.98 |
| Shares outstanding | 64.8M | 64.6M | 64.6M | 64.6M | 64.6M | 58.7M | 52.3M | 39.1M | 19.8M | 19.8M |
| Change in shares outstanding | +0.4% | −0.0% | 0.0% | 0.0% | +10.0% | +12.1% | +33.8% | +97.3% | 0.0% | — |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | 8.8% | 10.5% | 11.0% | 9.5% | 11.1% | 0.8% | 9.7% | 3.5% | 6.3% | 0.6% |
| Return on invested capital (ROIC) | 7.1% | 5.0% | 5.2% | 6.5% | 4.9% | 0.3% | 2.3% | 5.7% | 3.9% | 0.3% |
| Return on assets (ROA) | 3.7% | 4.7% | 4.9% | 4.1% | 4.6% | 0.3% | 4.4% | 1.9% | 3.3% | 0.3% |
| Return on tangible assets | 3.7% | 4.5% | 5.0% | 4.1% | 4.7% | 0.3% | 3.7% | 1.5% | 2.0% | 0.3% |
| Free cash flow margin | 12.3% | 52.9% | 57.7% | −271.9% | 214.1% | 642.8% | −256.3% | — | — | — |
| Income quality (OCF / net income) | 0.30 | 0.94 | 1.02 | −3.00 | 2.22 | 10.80 | −2.48 | −29.06 | −36.13 | −165.47 |
| Financial health | ||||||||||
| Total debt | $1.47B | $1.39B | $1.26B | $1.39B | $1.41B | $1.46B | $1.57B | $634.9M | $451.0M | $59.1M |
| Cash & short-term investments | $135.3M | $53.5M | $49.4M | $59.8M | $117.4M | $54.7M | $37.3M | $15.3M | $140.9M | $66.7M |
| Net debt | $1.34B | $1.34B | $1.21B | $1.33B | $1.30B | $1.40B | $1.54B | $619.6M | $310.1M | −$7.6M |
| Debt / equity | 1.32 | 1.22 | 1.11 | 1.24 | 1.29 | 1.37 | 1.55 | 0.63 | 0.89 | 0.54 |
| Debt / assets | 0.55 | 0.53 | 0.51 | 0.53 | 0.55 | 0.56 | 0.60 | 0.35 | 0.46 | 0.33 |
| Net debt / EBITDA | 7.09 | 10.79 | 9.52 | 8.34 | 14.10 | 164.51 | 15.67 | 12.23 | 13.34 | −12.32 |
| Current ratio | 0.35 | 1.92 | 1.80 | 2.22 | 3.30 | 1.89 | 2.11 | 0.22 | 4.98 | 9.86 |
| Quick ratio | 0.35 | 1.92 | 1.80 | 0.26 | −1.21 | −0.44 | −0.78 | 0.03 | 4.98 | 9.88 |
| Interest coverage | 2.2 | 1.7 | 1.6 | 3.0 | 2.3 | 0.1 | 1.5 | 2.9 | 5.0 | 58.2 |
| Working capital | −$392.4M | $94.2M | $40.5M | $111.0M | $129.2M | $39.5M | $43.6M | −$114.5M | $120.4M | $60.6M |
| Invested capital | $2.45B | $2.48B | $2.34B | $2.44B | $2.40B | $2.47B | $2.56B | $1.62B | $817.0M | $102.7M |
| Tangible asset value | $1.12B | $1.14B | $1.14B | $1.12B | $1.10B | $1.07B | $1.02B | $1.00B | $507.0M | $110.3M |
| Net current asset value | −$1.34B | −$1.30B | −$1.24B | −$1.27B | −$1.29B | −$1.45B | −$1.54B | −$757.5M | −$330.6M | $977,781 |
| Graham number | $24.31 | $27.10 | $27.51 | $25.21 | $26.67 | $7.60 | $28.65 | $19.81 | $23.67 | $1.96 |
| Graham net-net per share | −$20.91 | −$21.33 | −$19.44 | −$19.79 | −$18.22 | −$23.98 | −$28.65 | −$19.13 | −$16.97 | $0.03 |
| Capital allocation | ||||||||||
| Dividends paid | $145.8M | $114.3M | $99.4M | $87.8M | $87.8M | $86.3M | $81.2M | $41.0M | $7.8M | $7.8M |
| Share buybacks (net) | — | — | — | — | — | — | $0 | $0 | $0 | $0 |
| Dividend payout ratio | 147.7% | 95.7% | 80.6% | 83.2% | 73.3% | — | 82.8% | 153.8% | 40.2% | — |
| Dividends + buybacks / free cash flow | 493.9% | 101.5% | 79.0% | — | 33.1% | 96.5% | — | — | — | — |
| Capex / revenue | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Capex / operating cash flow | 0.0% | 0.0% | 0.0% | — | 0.0% | 0.0% | — | — | — | — |
| Capex / depreciation | 0.00 | — | — | 0.00 | — | 0.00 | 0.00 | — | 0.00 | 0.00 |
| R&D / revenue | — | — | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| SG&A / revenue | 4,715.4% | 6.7% | 5.2% | 8.1% | 6.9% | 62.9% | 8.0% | 5.2% | 11.2% | 28.5% |
| Efficiency | ||||||||||
| Days sales outstanding | 118.2 | 106.4 | 90.1 | 210.1 | 143.0 | 979.7 | 119.5 | 54.5 | 44.7 | 106.3 |
| Days of inventory on hand | — | — | — | 1,451.3 | 1,312.9 | 1,088.2 | 238.2 | 9,646.4 | -13.6 | -55.3 |
| Days payables outstanding | 265.9 | 156.6 | 90.5 | 110.0 | 102.8 | 268.2 | 314.2 | 57,639.2 | 1,120.8 | 2,705.2 |
| Cash conversion cycle (days) | -147.7 | -50.2 | -0.4 | 1,551.4 | 1,353.1 | 1,799.7 | 43.5 | -47,938.3 | -1,089.7 | -2,654.1 |
| Receivables turnover | 3.09 | 3.43 | 4.05 | 1.74 | 2.55 | 0.37 | 3.05 | 6.70 | 8.17 | 3.43 |
| Payables turnover | 1.37 | 2.33 | 4.03 | 3.32 | 3.55 | 1.36 | 1.16 | 0.01 | 0.33 | 0.13 |
| Inventory turnover | — | — | — | 0.25 | 0.28 | 0.34 | 1.53 | 0.04 | — | — |
| Asset turnover | 0.09 | 0.08 | 0.09 | 0.05 | 0.05 | 0.01 | 0.04 | 0.05 | 0.04 | 0.01 |
| Average receivables | $77.5M | $62.1M | $53.8M | $67.1M | $48.6M | $37.3M | $31.0M | $11.0M | $3.0M | $616,579 |
| Average payables | $40.3M | $32.0M | $19.8M | $16.4M | $14.0M | $26.7M | $92.8M | $81.2M | $11.4M | $6.8M |
| Average inventory | — | — | — | $215.7M | $178.3M | $108.3M | $70.3M | $13.6M | −$138,830 | −$139,876 |
| Intangibles / total assets | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Computed from BCSF's annual financial statements (latest annual report filed February 27, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
BCSF valuation and financial ratios
At the end of fiscal 2025 (December 31, 2025), Bain Capital Specialty Finance traded at 9.1 times earnings, against a 10-year median of 9.3. Based on the latest twelve months, the trailing P/E is 10.4 and the forward P/E is 10.1. Bain Capital Specialty Finance earned a return on equity of 8.8% and a return on invested capital of 7.1% in fiscal 2025. It ended the year with $1.5 billion of debt and $135.3 million in cash and short-term investments, net debt of $1.3 billion. It returned $145.8 million to shareholders: $145.8 million in dividends and $0 in share buybacks, 494% of free cash flow. The share count rose 227.0% from 19.8M to 64.8M over 9 years.
See the BCSF income statement, the BCSF chart for price history, or the BCSF stock overview for the latest quote and news.
BCSF key metrics FAQ
What is Bain Capital Specialty Finance's P/E ratio?
Bain Capital Specialty Finance's trailing P/E ratio is 10.4 based on the last twelve months of earnings (as of October 17, 2026), and its forward P/E is 10.1. At the end of fiscal 2025 it was 9.1, compared with a 10-year median of 9.3.
What is Bain Capital Specialty Finance's EV/EBITDA?
Bain Capital Specialty Finance's enterprise value was 11.9 times EBITDA at the end of fiscal 2025 (enterprise value $2.2 billion, EBITDA $188.3 million); the current EV/EBITDA is 21.9.
What is Bain Capital Specialty Finance's return on equity?
Bain Capital Specialty Finance's return on equity (ROE) was 8.8% in fiscal 2025: net income of $98.8 million on average shareholders' equity of $1.1 billion.
What is Bain Capital Specialty Finance's ROIC?
Bain Capital Specialty Finance's return on invested capital was 7.1% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Bain Capital Specialty Finance have?
Bain Capital Specialty Finance had total debt of $1.5 billion at the end of fiscal 2025, a debt-to-equity ratio of 1.32 and $1.3 billion of net debt (7.09 times EBITDA).
What is Bain Capital Specialty Finance's dividend yield?
Bain Capital Specialty Finance's forward dividend yield is 16.37%. Bain Capital Specialty Finance paid $145.8 million in dividends in fiscal 2025 ($2.25 per share), a payout ratio of 147.7%.
What is Bain Capital Specialty Finance's free cash flow yield?
Bain Capital Specialty Finance generated $29.5 million of free cash flow in fiscal 2025, a free cash flow yield of 3.3% on its market value at year-end ($901.7 million).
What is Bain Capital Specialty Finance's current ratio?
Bain Capital Specialty Finance's current ratio was 0.35 at the end of fiscal 2025: current assets were 0.35 times current liabilities.